Skip to content

HPV Message Testing and Social Media Campaign

HPV Message Testing and Social Media Campaign

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03747302
Enrollment
1043
Registered
2018-11-20
Start date
2018-12-12
Completion date
2019-09-09
Last updated
2022-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papilloma Virus, Vaccine

Keywords

Adolescence, Attitudes, Parents, Vaccination

Brief summary

This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Interventions

OTHERSocial Media Message about HPV and HPV vaccine

Messages educate parents with facts about HPV vaccination.

OTHERSocial media message about risk of electronic cigarettes.

Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Norris Cotton Cancer Center
CollaboratorOTHER
Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Masking description

Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* parents of children 9-14 years old

Exclusion criteria

* non-parents

Design outcomes

Primary

MeasureTime frameDescription
Change in Attitudes About HPV VaccinePost test completed < 1 hour post messaging interventionChange in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(\<1 hour post messaging intervention) minus value at baseline.

Secondary

MeasureTime frameDescription
Behavioral Intention to Vaccinate Their Child With HPV VaccineOre test immediately before viewing message and post- test immediately after viewing message. Approximately one hour.A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely). HPV vaccination behavioral intent change scores were calculated by subtracting pre- and post- test values. It is a negative-value scale, in which smaller values indicate more positive attitude change after exposure to the viewed message.

Countries

United States

Participant flow

Recruitment details

1713 prospective participants responded to a social media or MTurk posting about the study between 12/12/18 to 04/15/19. 39 declined to consent. Of the remaining 1674 participants: 631 had no child and were deemed ineligible,.1043 people were eligible and consented to be in the study. Of that, 45 dropped before random assignment. As such, 998 people were eligible, provided a consent, and completed a baseline survey.

Pre-assignment details

Eligible, consented participants completed a pre-test survey prior to assignment to an arm.

Participants by arm

ArmCount
HPV Messaging
834 Subjects are randomized to receive one of five messages on one of the five themes about HPV vaccination.(165-167/group) Social Media Message about HPV and HPV vaccine: Messages educate parents with facts about HPV vaccination.
834
Control Message
164 Subjects are randomized to receive one of five messages about electronic cigarettes. Social media message about risk of electronic cigarettes.: Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.
164
Total998

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject12

Baseline characteristics

CharacteristicControl MessageTotalHPV Messaging
Age, Continuous37.33 years
STANDARD_DEVIATION 10.88
37.93 years
STANDARD_DEVIATION 10.77
38.05 years
STANDARD_DEVIATION 10.75
HPV Vaccine in prevents Cervical Cancer2.48 units on a scale
STANDARD_DEVIATION 1.5
2.52 units on a scale
STANDARD_DEVIATION 1.56
2.53 units on a scale
STANDARD_DEVIATION 1.58
HPV Vaccine in prevents Throat Cancer2.08 units on a scale
STANDARD_DEVIATION 1.81
2.23 units on a scale
STANDARD_DEVIATION 1.8
2.26 units on a scale
STANDARD_DEVIATION 1.8
Prior knowledge of HPV142 Participants872 Participants730 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
96 Participants616 Participants520 Participants
Sex: Female, Male
Male
68 Participants382 Participants314 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Change in Attitudes About HPV Vaccine

Change in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(\<1 hour post messaging intervention) minus value at baseline.

Time frame: Post test completed < 1 hour post messaging intervention

Population: 1 participant in the experimental group and 2 participants in the control group withdrew from the study and are not included in the analysis.

ArmMeasureValue (MEAN)Dispersion
HPV MessagingChange in Attitudes About HPV Vaccine.16 units on a scaleStandard Deviation 0.92
Control MessagingChange in Attitudes About HPV Vaccine-.08 units on a scaleStandard Deviation 0.91
p-value: 0.003t-test, 2 sided
Secondary

Behavioral Intention to Vaccinate Their Child With HPV Vaccine

A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely). HPV vaccination behavioral intent change scores were calculated by subtracting pre- and post- test values. It is a negative-value scale, in which smaller values indicate more positive attitude change after exposure to the viewed message.

Time frame: Ore test immediately before viewing message and post- test immediately after viewing message. Approximately one hour.

Population: A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely).

ArmMeasureValue (MEAN)Dispersion
HPV MessagingBehavioral Intention to Vaccinate Their Child With HPV Vaccine-.022 units on a scaleStandard Deviation 0.81
Control MessagingBehavioral Intention to Vaccinate Their Child With HPV Vaccine-.06 units on a scaleStandard Deviation 0.92
Comparison: Change in mean scores for behavioral intent to vaccine: negative values: smaller values indicate more likely to vaccinate.p-value: >0.05t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026